HARVARD BIOSCIENCE, INC. Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount
HARVARD BIOSCIENCE, INC. (HBIO) reported Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount of -$11.96 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-13.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate · last filed 2026-03-13
- HARVARD BIOSCIENCE, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2025 was -$11.96M.
- HARVARD BIOSCIENCE, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2024 was -$2.45M.
- HARVARD BIOSCIENCE, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2023 was -$537.00K.
- HARVARD BIOSCIENCE, INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2022 was -$1.93M.
| Period end | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 12 month | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$11.96M 10-K · filed 2026-03-13 | |
| 2024-12-31 | -$2.45M 10-K · filed 2026-03-13 | |
| 2023-12-31 | -$537.00K 10-K · filed 2025-03-14 | |
| 2022-12-31 | -$1.93M 10-K · filed 2024-03-07 | |
| 2021-12-31 | -$29.00K 10-K · filed 2023-03-09 | |
| 2020-12-31 | -$1.53M 10-K · filed 2022-03-11 | |
| 2019-12-31 | -$1.16M 10-K/A · filed 2021-03-17 | |
| 2018-12-31 | -$1.67M 10-K · filed 2020-03-16 | |
| 2017-12-31 | -$892.00K 10-K · filed 2019-03-18 | -$710.00K 10-K · filed 2018-03-16 |
| 2016-12-31 | -$1.05M 10-K · filed 2018-03-16 | |
| 2015-12-31 | -$1.23M 10-K · filed 2018-03-16 | |
| 2014-12-31 | $1.50M 10-K · filed 2017-03-17 | |
| 2013-12-31 | $147.00K 10-K · filed 2016-04-29 | |
| 2012-12-31 | $2.34M 10-K · filed 2015-03-12 | $756.00K 10-K · filed 2013-03-18 |
| 2011-12-31 | $2.33M 10-K · filed 2014-03-14 | $1.54M 10-K · filed 2013-03-18 |
| 2010-12-31 | $3.25M 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |